Due to scheduled maintenance, the clinical trials search and listings may be intermittently unavailable on the evening of Thursday, 10/20/2016, from 7 pm-midnight.
We apologize for the inconvenience. If you have any clinical trials questions during that period, please call 888-FOX-CHASE.


Prostate Cancer Diagnosis

Prostate cancer treatment is more effective when the cancer is diagnosed early. Doctors at Fox Chase Cancer Center use several screening tools to detect prostate cancer.

  • PSA Test - Measures the amount of prostate-specific antigen, or PSA, in the blood. PSA is a protein produced by the prostate and can indicate the presence of cancer.
  • Digital Rectal Examination (DRE) - Your doctor inserts a gloved finger into the rectum to detect any lumps in the prostate.
  • Fusion Biopsy – Pre-biopsy images of the prostate are combined with ultrasound-guided biopsy images in real time to create a detailed, three-dimensional view of the prostate, reducing chances that an aggressive form of prostate cancer is missed.

Fusion Biopsy

At Fox Chase, we offer the latest in imaging and prostate biopsy technology in order to improve the care we can offer to our patients. Employing the power of the technique called multiparametric magnetic resonance imaging (mp-MRI), our world-class radiology team can localize tumors within the prostate with a high degree of accuracy, identifying tumors that historically went unrecognized. This technology can give patients piece of mind that aggressive disease is not being missed and uncover aggressive cancer in some individuals with tumors in uncommon and remote locations in the prostate.

Using UroNav Ultrasound (US)/MRI fusion technology, which allows precise targeting with biopsy to evaluate lesions found on mp-MRI, we are now less likely to miss aggressive disease and, thus, potentially minimize the need for repeated prostate biopsies in the future. Furthermore, we can better assure men who choose active surveillance for low-risk prostate cancer that an aggressive tumor is not missed or overlooked. Indeed, Fox Chase is one of the first institutions in the Delaware Valley to offer US/MRI fusion capabilities to patients undergoing prostate biopsy.

If you or your loved one have an elevated PSA and are contemplating a biopsy, are due for a repeat prostate biopsy for suspected prostate cancer, or are on active surveillance for prostate cancer, we encourage you to consider getting an opinion with our prostate cancer team to see if US/MRI fusion technology can be a helpful addition to your clinical evaluation.

Dr. Alexander Kutikov describes the fusion biopsy system Fox Chase Cancer Center uses. It allows better assurance that tumors are located precisely in a prostate biopsy. (2:46)